Analysts expect Kyntra Bio, Inc. to report revenue of 1.95 M for Q3 26, against a range of 1.80 M to 2.10 M. The most recent reported quarter, Q2 26, came in at -1.50 M, a 167.7% miss against the 2.22 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 46.33 M | 3.14 M | 2.70 M | 1.30 M | 1.08 M | 1.30 M | 3.70 M | -1.50 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 35.33 M | 25.66 M | 1.62 M | 2.87 M | 2.58 M | 1.84 M | 1.59 M | 2.36 M | 2.10 M | 2.55 M | 1.23 M | 1.39 M | 1.21 M | 1.34 M | 1.37 M | 1.28 M | ||||||||||
| Low Estimate | 32.94 M | 22.10 M | 1.40 M | 2.51 M | 2.13 M | 1.58 M | 1.45 M | 2.07 M | 1.80 M | 2.40 M | 1.11 M | 1.17 M | 1.13 M | 1.23 M | 1.27 M | 1.12 M | ||||||||||
| Consensus Estimate | 34.14 M | 23.88 M | 1.51 M | 2.69 M | 2.36 M | 1.71 M | 1.52 M | 2.22 M | 1.95 M | 2.47 M | 1.17 M | 1.28 M | 1.17 M | 1.29 M | 1.32 M | 1.20 M |
Analysts expect Kyntra Bio, Inc. to report earnings per share of -3.90 for Q3 26, against a range of -4.23 to -3.57. The most recent reported quarter, Q2 26, came in at 2.96, a 190.2% beat against the -3.28 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -4.25 | 4.50 | 1.25 | -1.88 | 49.61 | -3.51 | -3.76 | 2.96 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -7.44 | -3.26 | 0.81 | -2.01 | -3.89 | -3.62 | -2.91 | -3.09 | -3.57 | -4.46 | -2.92 | -2.98 | -2.86 | -2.69 | -2.89 | -2.77 | ||||||||||
| Low Estimate | -8.40 | -3.98 | 0.75 | -2.39 | -4.69 | -3.88 | -3.41 | -3.47 | -4.23 | -5.24 | -3.14 | -3.58 | -3.40 | -3.13 | -3.47 | -3.01 | ||||||||||
| Consensus Estimate | -7.92 | -3.62 | 0.78 | -2.20 | -4.29 | -3.75 | -3.16 | -3.28 | -3.90 | -4.85 | -3.03 | -3.28 | -3.13 | -2.91 | -3.18 | -2.89 |
Pull Wall Street consensus for Kyntra Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=KYNB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "KYNB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=KYNB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();